Novavax (NVAX) EBITDA Margin Growth (5y) (2015 - 2026)
Novavax (NVAX) EBITDA Margin Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Novavax |
1.49 Bn |
931.98 Mn |
108.82 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
3,559.00 |
| Dec 31, 2025 |
7,506.00 |
| Sep 30, 2025 |
-12,919.00 |
| Jun 30, 2025 |
10,567.00 |
| Mar 31, 2025 |
75,536.00 |
| Dec 31, 2024 |
17,717.00 |
| Sep 30, 2024 |
43,923.00 |
| Jun 30, 2024 |
113,097.00 |
| Mar 31, 2024 |
85,581.00 |
| Dec 31, 2023 |
69,612.00 |
| Sep 30, 2023 |
47,451.00 |
| Jun 30, 2023 |
40,286.00 |
| Mar 31, 2023 |
6,440.00 |
| Dec 31, 2022 |
39,069.00 |
| Sep 30, 2022 |
48,110.00 |
| Jun 30, 2022 |
35,627.00 |
| Mar 31, 2022 |
74,850.00 |
| Sep 30, 2021 |
178,765.00 |
| Jun 30, 2021 |
293,777.00 |
| Mar 31, 2021 |
173,766.00 |
